Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy A Chan

Showing results (171-180 of 271) with videos related to

Pageof 28
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarkerM Catherine Pietanza, Kyuichi Kadota, Kety Huberman, et al.
Nature Genetics|June 2, 2025
Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic disseminationKarena Zhao, Joris Vos, Stanley Lam, et al.
Nature|February 21, 2012
IDH mutation impairs histone demethylation and results in a block to cell differentiationChao Lu, Patrick S Ward, Gurpreet S Kapoor, et al.
Nature Immunology|May 26, 2022
Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignanciesEmily R Kansler, Saïda Dadi, Chirag Krishna, et al.
Neuro-Oncology|December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant gliomaAntonio Omuro, Timothy A Chan, Lauren E Abrey, et al.
Journal of the American Heart Association|March 10, 2026
Specific Deficiency of Naïve CD4+ T Lymphocytes Characterizes Heart Failure and Heightens Mortality Risk in the HRSDavid A Zidar, Michael L Freeman, Brigid M Wilson, et al.
Science Immunology|September 15, 2019
RIG-I activation is critical for responsiveness to checkpoint blockadeSimon Heidegger, Alexander Wintges, Florian Stritzke, et al.
Nature Immunology|June 15, 2022
Author Correction: Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignanciesEmily R Kansler, Saïda Dadi, Chirag Krishna, et al.
The Journal of Clinical Investigation|March 16, 2026
T cell-intrinsic VISTA expression promotes resistance to CTLA-4 blockade by restricting CD8+ T cell responsesCassandra Gilmour, Elizabeth DeLaney, Prerana B Parthasarathy, et al.
Science (New York, N.Y.)|December 9, 2017
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapyDiego Chowell, Luc G T Morris, Claud M Grigg, et al.
Pageof 28

Showing results (171-180 of 271) with videos related to

Sort By:
Pageof 28
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 10, 2012
Phase II trial of temozolomide in patients with relapsed sensitive or refractory small cell lung cancer, with assessment of methylguanine-DNA methyltransferase as a potential biomarkerM Catherine Pietanza, Kyuichi Kadota, Kety Huberman, et al.
Nature Genetics|June 2, 2025
Longitudinal and multisite sampling reveals mutational and copy number evolution in tumors during metastatic disseminationKarena Zhao, Joris Vos, Stanley Lam, et al.
Nature|February 21, 2012
IDH mutation impairs histone demethylation and results in a block to cell differentiationChao Lu, Patrick S Ward, Gurpreet S Kapoor, et al.
Nature Immunology|May 26, 2022
Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignanciesEmily R Kansler, Saïda Dadi, Chirag Krishna, et al.
Neuro-Oncology|December 18, 2012
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant gliomaAntonio Omuro, Timothy A Chan, Lauren E Abrey, et al.
Journal of the American Heart Association|March 10, 2026
Specific Deficiency of Naïve CD4+ T Lymphocytes Characterizes Heart Failure and Heightens Mortality Risk in the HRSDavid A Zidar, Michael L Freeman, Brigid M Wilson, et al.
Science Immunology|September 15, 2019
RIG-I activation is critical for responsiveness to checkpoint blockadeSimon Heidegger, Alexander Wintges, Florian Stritzke, et al.
Nature Immunology|June 15, 2022
Author Correction: Cytotoxic innate lymphoid cells sense cancer cell-expressed interleukin-15 to suppress human and murine malignanciesEmily R Kansler, Saïda Dadi, Chirag Krishna, et al.
The Journal of Clinical Investigation|March 16, 2026
T cell-intrinsic VISTA expression promotes resistance to CTLA-4 blockade by restricting CD8+ T cell responsesCassandra Gilmour, Elizabeth DeLaney, Prerana B Parthasarathy, et al.
Science (New York, N.Y.)|December 9, 2017
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapyDiego Chowell, Luc G T Morris, Claud M Grigg, et al.
Pageof 28